Barriers to self-injection of insulin among patients attending the diabetes clinics at the three referral hospitals in Bhutan: a cross-sectional study

2018 ◽  
Vol 4 (2) ◽  
pp. 1-5
Author(s):  
Thinley Dorji ◽  
Pema Lhamo ◽  
Tshering Tshering ◽  
Lungten Zangmo ◽  
Kencho Choden ◽  
...  

Introduction: Insulin, despite its increasing cost, is prescribed to selected cases of diabetes patients with an aim to achieve good glycaemic control. However, many on insulin do not achieve glycaemic control. We, therefore, studied the possible factors that may act as barriers to effective self-injection of insulin among diabetes patients at the three referral hospitals in Bhutan. Methods: This was a cross-sectional study, conducted from January-June 2017, involving all patients on insulin therapy for more than three months duration. Convenience sampling was used. Respondents’ basic details and self-reported barriers to insulin therapy under various domains were collected using an interviewer-administered questionnaire. Ethics approval was granted by the Research Ethics Board of Health, Bhutan. Results: There were 207 respondents on insulin therapy. The mean age of the sample was 55 years (±13.8 years) and the mean duration of diabetes was 10.6 years (± 7.8 years). Injection dexterity was an issue in 77 respondents (37.2%) while 37 respondents (17.8%) reported that they would miss their insulin shots if their caregiver were unavailable. Insulin regimens were burdensome and interfered with their daily activities (80; 38.7%) and meal timings (64; 30.9%). Although the majority (179; 86.4%) knew why insulin was indicated for them, 149 (72.0%) found that the healthcare personnel’s demonstration on the use of insulin was inadequate and 50 respondents (24.2%) felt that they did not receive enough information on how to inject insulin. Conclusions: Barriers to self-injection are common among insulin users and coordinated efforts are needed to overcome them.

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Berhanu Elfu Feleke ◽  
Teferi Elfu Feleke ◽  
Melkamu Beyene Kassahun ◽  
Wondemu Gebrekirose Adane ◽  
Netsanet Fentahun ◽  
...  

Background. Glycemic control is the level of glucose in diabetes patient. Evidence regarding glycemic control is scarce in resource-limited settings, and this study was conducted to generate information regarding the prevalence and predictors of glycemic control among diabetes mellitus patients attending their care from the referral hospitals of the Amhara region, Ethiopia. Methods. A cross-sectional study design was implemented. A simple random sampling technique was used. Data were collected from March 2018 to January 2020. The data were collected using interviews, chart review, and blood samples. Hemoglobin A1c was measured using high-performance liquid chromatography. Data were entered into Epi-info software and analyzed by SPSS software. Descriptive statistics were used to estimate the prevalence of glycemic control; linear regression was used to identify the predictors of HbA1c. Results. A total of 2554 diabetes patients were included giving for the response rate of 95.83%. The mean age of the study participants was 54.08 years [ SD   standard   deviation ± 8.38   years ]. The mean HbA1c of the study participants was 7.31% [ SD ± 0.94 % ]. Glycemic control was poor in 55.32% [95% CI: 53.4%-57.25%] of diabetes patients. The glycemic control of diabetes patients was determined by BMI (β 0.1; [95% CI: 0.09-0.1]), type 2 diabetes (β -0.14; [95% CI: -0.11-0.16]), age (β 0.22; [95% CI: 0.02-0.024]), duration of the disease (β 0.04; [95% CI: 0.037-0.042]), the presence of hypertension (β 0.12; [95% CI:0.09–0.16]), regular physical exercise (β -0.06; [95% CI: -0.03-0.09]), medication adherence (β -0.16; [95% CI: -0.14-0.18]), and male (β 0.34; [95% CI: 0.31-.037]). Conclusion. The glycemic control of diabetes patients was poor, and it needs the attention of decision-makers.


Sign in / Sign up

Export Citation Format

Share Document